Jeff Allen, Ph.D.
Dr. Jeff Allen serves as the executive director of Friends of Cancer Research (Friends), a cancer research think tank based in the Washington, D.C. area. Working with the entire cancer research and advocacy community, Friends pioneers innovative public-private partnerships, organizes critical policy forums, educates the public, and brings together key stakeholders to overcome the barriers standing between patients and the most promising cancer treatments. Prior to joining Friends, Dr. Allen was an endocrinology fellow in the Laboratory of Clinical Investigation of the National Center for Complementary and Alternative Medicine at the National Institutes of Health. His background in cancer research focused upon molecular changes associated with cancer formation as well as treatments to prevent cancer progression. Dr. Allen has been published in numerous policy and medical journals. Dr. Allen serves on C-Change’s Chemoprevention Advisory Committee, Patent Law Advisory Subcommittee, and the Clinical Trials and Biomarker Workgroup. Allen is also a member of the National Health Council FDA Issue Team, serves on the Global Access Project of the National Patient Advocacy Foundation, and was recently named to the National Cancer Institute Director’s Consumer Liaison Group federal advisory committee. Jeff is also a thought leader in comparative effectiveness research and recently served as the organizing author of a 2009 report, "Improving Medical Decisions Through Comparative Effectiveness Research: Cancer as a Case Study," co-authored by a 25 member academic committee. Dr. Allen received his PhD in cell and molecular biology from Georgetown University, and holds a Bachelor of Science in Biology (cum laude) from Bowling Green State University.